 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Deltec Asset Management LLC purchased a new stake in shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK  Free Report) during the 2nd quarter, according to its most recent 13F filing with the...

Deltec Asset Management LLC Takes $156,000 Position in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Gurnet Point, Novo complete acquisition of Paratek Pharmaceuticals

BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. ( Paratek ) (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of...

Paratek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and Novo Holdings A/S

Follows the recommendation from ISS to vote FOR the transactionBOSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. ("Paratek") (Nasdaq: PRTK), a commercial-stage...

Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote FOR the Acquisition by Gurnet Point Capital and Novo Holdings A/S

NEW YORK, Sept. 10, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCCI, KLR, PRTK

BOSTON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. ("Paratek") (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of...

Leading Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote FOR the Acquisition by Gurnet Point Capital and Novo Holdings

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, NEWR, PRTK SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, NEWR, PRTK PR Newswire NEW YORK, Aug. 28, 2023 NEW YORK, Aug. 28, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, NEWR, PRTK

StockNews.com initiated coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK  Get Free Report) in a report issued on Friday. The firm set a hold rating on the specialty pharmaceutical companys stock. PRTK has been the subject of a number of other research reports. ...

StockNews.com Initiates Coverage on Paratek Pharmaceuticals (NASDAQ:PRTK)

NEW YORK, Aug. 27, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Crestwood Equity Partners LP (NYSE: CEQP)s sale...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CEQP, CELL, DINO, PRTK

StockNews.com began coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK Free Report) in a research report report published on Friday. The firm issued a hold rating on the specialty pharmaceutical companys stock. A number of other equities research analysts have also recently weighed in on the...

Paratek Pharmaceuticals (NASDAQ:PRTK) Receives New Coverage from Analysts at StockNews.com

Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections. The company was founded by Walter Gilbert and Stuart B. Levy in 1996 and is headquartered in Boston, MA.

Watchers	4,746
52-Wk Low	$1.29
52-Wk High	$3.65

Market Cap	$127.83M
Volume (M)	4.76M
52-Wk High	$3.65
52-Wk Low	$1.29

PRTK Paratek Pharmaceuticals Inc.

About

Feed

News

Earnings

Fundamentals